Jun 21 |
Syndax: Gearing Up For Launches
|
Jun 14 |
Syndax Presents Updated Positive Data from BEAT AML and AUGMENT-102 Phase 1/2 Combination Trials of Revumenib in Patients with Acute Leukemias at EHA 2024 Congress
|
Jun 10 |
Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger
|
Jun 6 |
Syndax Announces Plans to Advance into Phase 1b Portion of Trial Evaluating Revumenib in Relapsed or Refractory Metastatic MSS CRC
|
Jun 5 |
Syndax Announces Participation at the Goldman Sachs 45th Annual Global Healthcare Conference
|
May 29 |
Why Ooma Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
|
May 15 |
Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors
|
May 12 |
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2024 Earnings Call Transcript
|
May 9 |
Syndax Announces Participation at the Bank of America Securities 2024 Health Care Conference
|
May 9 |
Syndax Pharmaceuticals Inc (SNDX) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
|